Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages

Breast Cancer Research and Treatment

Volumn 137, Issue 3, 2013, Pages 733-744

  Alkhateeb, Ahmed A ^a   Han, Bing ^a   Connor, James R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Cancer associated inflammation; Ferritin; Iron; Tumor associated macrophages

Indexed keywords

FERRITIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; IRON; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BREAST TUMOR; CELL PROLIFERATION; EXTRACELLULAR SPACE; FEMALE; MACROPHAGE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SPACE; FEMALE; FERRITINS; HUMANS; IRON; MACROPHAGES; RATS; TUMOR MICROENVIRONMENT;

MLCS; MLOWN;

EID: 84879334969     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2405-x     Document Type: Article

References (48)

1. Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275(3):161-203
2. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW (1985) Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 260(21):11755-11761
3. Lawson DM, Artymiuk PJ, Yewdall SJ, Smith JM, Livingstone JC, Treffry A, Luzzago A, Levi S, Arosio P, Cesareni G et al (1991) Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 349(6309):541-544. doi: 10.1038/349541a0
4. Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, Luzzago A, Cesareni G, Levi S, Arosio P (1989) Identification of the ferroxidase centre in ferritin. FEBS Lett 254(1-2):207-210
5. Levi S, Yewdall SJ, Harrison PM, Santambrogio P, Cozzi A, Rovida E, Albertini A, Arosio P (1992) Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J 288(Pt 2):591-596
6. Todorich B, Zhang X, Connor JR (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59(6):927-935. doi: 10.1002/glia.21164
7. Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 107(6):1495-1505. doi: 10.1111/j.1471-4159.2008.05678.x
8. Coffman LG, Parsonage D, D'Agostino R Jr, Torti FM, Torti SV (2009) Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci USA 106(2):570-575. doi: 10.1073/pnas.0812010106
9. Tesfay L, Huhn AJ, Hatcher H, Torti FM, Torti SV (2012) Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells. PLoS ONE 7(7):e40030. doi: 10.1371/journal.pone.0040030
10. Alkhateeb A, Leitzel K, Ali SM, Campbell-Baird C, Evans M, Fuchs E, Köstler WJ, Lipton A, Connor J (2012) Elevation in serum inflammatory biomarkers predicts response to trastuzumab-containing therapy. PLoS ONE 7(12):e51379. doi: 10.1371/journal.pone.0051379
11. Jones BM, Worwood M, Jacobs A (1980) Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin. Clin Chim Acta 106(2):203-214
12. Robertson JF, Pearson D, Price MR, Selby C, Pearson J, Blamey RW, Howell A (1991) Prospective assessment of the role of five tumour markers in breast cancer. Cancer Immunol Immunother 33(6):403-410
13. Mannello F, Tonti GA, Medda V, Simone P, Darbre PD (2011) Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients. J Appl Toxicol 31(3):262-269. doi: 10.1002/jat.1641
14. Tappin JA, George WD, Bellingham AJ (1979) Effect of surgery on serum ferritin concentration in patients with breast cancer. Br J Cancer 40(4):658-660
15. Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY (1976) Serum ferritin concentration in early breast cancer. Br J Cancer 34(3):286-290
16. Arosio P, Yokota M, Drysdale JW (1977) Characterization of serum ferritin in iron overload: possible identity to natural apoferritin. Br J Haematol 36(2):199-207
17. Weinstein RE, Bond BH, Silberberg BK (1982) Tissue ferritin concentration in carcinoma of the breast. Cancer 50(11):2406-2409
18. Weinstein RE, Bond BH, Silberberg BK, Vaughn CB, Subbaiah P, Pieper DR (1989) Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res Treat 14(3):349-353
19. Rossiello R, Carriero MV, Giordano GG (1984) Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 37(1):51-55
20. Jezequel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guerin-Charbonnel C, Joalland MP, Andre J, Descotes F, Grenot C, Roy P, Carlioz A, Martin PM, Chassevent A, Jourdan ML, Ricolleau G (2012) Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: a multicentric 2004 national PHRC study. Int J Cancer 131(2):426-437. doi: 10.1002/ijc.26397
21. Snyder AM, Neely EB, Levi S, Arosio P, Connor JR (2010) Regional and cellular distribution of mitochondrial ferritin in the mouse brain. J Neurosci Res 88(14):3133-3143. doi: 10.1002/jnr.22462
22. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71-78. doi: 10.1038/nrc1256
23. Simson JV, Spicer SS (1972) Ferritin particles in macrophages and in associated mast cells. J Cell Biol 52(3):536-541
24. Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, Sougrat R, Morgenstern A, Galy B, Hentze MW, Lazaro FJ, Rouault TA, Meyron-Holtz EG (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116(9):1574-1584. doi: 10.1182/blood-2009-11-253815
25. Li JY, Paragas N, Ned RM, Qiu A, Viltard M, Leete T, Drexler IR, Chen X, Sanna-Cherchi S, Mohammed F, Williams D, Lin CS, Schmidt-Ott KM, Andrews NC, Barasch J (2009) Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 16(1):35-46. doi: 10.1016/j.devcel.2008.12.002
26. Breuer W, Epsztejn S, Cabantchik ZI (1995) Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 270(41):24209-24215
27. Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, Santambrogio P, Arosio P, Ramm GA (2009) Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49(3):887-900. doi: 10.1002/hep.22716
28. Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP (2003) The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 5(6):495-506
29. Pinnix ZK, Miller LD, Wang W, D'Agostino R Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM (2010) Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2(43):43ra56. doi: 10.1126/scisignal.3001127
30. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66(23):11238-11246. doi: 10.1158/0008-5472.CAN-06- 1278
31. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM (2009) CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2):91-102. doi: 10.1016/j.ccr.2009.06.018
32. Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM (2012) Leukocyte composition of human breast cancer. Proc Natl Acad Sci USA 109(8):2796-2801. doi: 10.1073/pnas.1104303108
33. Chen Q, Zhang XH, Massague J (2011) Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 20(4):538-549. doi: 10.1016/j.ccr.2011.08.025
34. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirstrom K, West BL, Coussens LM (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028
35. Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, Simpson K, Bell-McGuinn KM, Zabor EC, Brogi E, Joyce JA (2011) Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev 25(23):2465-2479. doi: 10.1101/gad.180331.111
36. Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J, Carter HB, Marshall FF (1995) Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 45(2):211-217
37. Sato Y, Honda Y, Asoh T, Oizumi K, Ohshima Y, Honda E (1998) Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis. J Neurooncol 40(1):47-50
38. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC (1997) Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90(12):4979-4986
39. Ghosh S, Hevi S, Chuck SL (2004) Regulated secretion of glycosylated human ferritin from hepatocytes. Blood 103(6):2369-2376. doi: 10.1182/blood-2003-09-3050
40. Ferring-Appel D, Hentze MW, Galy B (2009) Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood 113(3):679-687. doi: 10.1182/blood-2008-05-155093
41. Singh M, Lu J, Briggs SP, McGinley JN, Haegele AD, Thompson HJ (1994) Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea- induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis 15(8):1567-1570
42. Diwan BA, Kasprzak KS, Anderson LM (1997) Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats. Carcinogenesis 18(9):1757-1762
43. Broxmeyer HE, Williams DE, Geissler K, Hangoc G, Cooper S, Bicknell DC, Levi S, Arosio P (1989) Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood 73(1):74-79
44. Cozzi A, Corsi B, Levi S, Santambrogio P, Biasiotto G, Arosio P (2004) Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood 103(6):2377-2383. doi: 10.1182/blood-2003-06-1842
45. Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomark Prev 11(12):1586-1591
46. Cotterchio M, Kreiger N, Sloan M, Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomark Prev 10(11):1213-1217
47. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G (2004) Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119(4):529-542. doi: 10.1016/j.cell.2004.10.017
48. Fleming DJ, Jacques PF, Massaro JM, D'Agostino RB Sr, Wilson PW, Wood RJ (2001) Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr 74(2):219-226